NASDAQ$ZYME

Zymeworks Inc · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Headline financials

Total Revenue

$16.5M

No prior period
EPS

-$0.41

No prior period
Capital Expenditures

-$2.12M

No prior period
Free Cash Flow

-$30.8M

No prior period
Net Income

-$28.7M

No prior period
Operating Income

-$33.2M

No prior period
Cash & Equivalents

$94.3M

No prior period
Total Assets

$556M

No prior period

Revenue & EPS history

Zymeworks · Revenue · Quarterly

$16.5M

Q3 2023
Beat estimate in 3 of 4 quarters(75%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 13 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

-1.2%

Avg return

Earnings day

-0.4%

Avg return

5 days after

+7.6%

Avg return

30 days after

38%

5 / 13 earnings

Positive

+1.4%

Q1 2023

Best reaction

-8.0%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.6%-13.5%-13.0%
Q4 2025+0.1%+3.4%+11.4%
Q3 2025-8.0%+8.2%+49.1%
Q1 2025-0.1%-0.6%+11.3%
Q4 2024-8.0%-11.2%-16.9%
Q3 2024+1.0%+1.2%+11.7%
Q2 2024+0.0%+4.3%+22.4%
Q1 2024+0.0%-8.3%-18.4%
Q4 2023+0.0%+1.6%+3.8%
Q3 2023+1.2%+0.1%+31.2%
Q3 2021+0.0%-1.3%+10.3%
Q2 2023+0.8%-3.6%-7.5%
Q1 2023+1.4%+14.1%+2.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro